Effect of different beta-adrenergic agonists on the intestinal absorption of galactose and phenylalanine.
Nutrient transport across the mammalian small intestine is regulated by several factors, including intrinsic and extrinsic neural pathways, paracrine modulators, circulating hormones and luminal agents. Because beta-adrenoceptors seem to regulate gastrointestinal functions such as bicarbonate and acid secretion, intestinal motility and gastrointestinal mucosal blood flow, we have investigated the effects of different beta-adrenergic agonists on nutrient absorption by the rat jejunum in-vitro. When intestinal everted sacs were used the beta2-agonist salbutamol had no effect either on galactose uptake by the tissue or mucosal-to-serosal flux whereas mixed beta1- and beta2-agonists (isoproterenol and orciprenaline) and beta3-agonists (BRL 35135, Trecadrine, ICI 198157 and ZD 7114) inhibited galactose uptake and transfer of D-galactose from the mucosal-to-serosal media across the intestinal wall (although the inhibiting effects of isoproterenol and Trecadrine were not statistically significant). In intestinal everted rings both Trecadrine and BRL 35135 clearly reduced galactose uptake, the effect being a result of inhibition of the phlorizin-sensitive component. Total uptake of phenylalanine by the intestinal rings was also reduced by those beta3-adrenergic agonists. These results suggest that beta1- and beta3-adrenergic receptors could be involved in the regulation of intestinal active transport of sugars and amino acids.
Díez-Sampedro
A
A
Department of Physiology and Nutrition, University of Navarra, Pamplona, Spain.
Pérez
M
M
Cobo
M T
MT
Martínez
J A
JA
Barber
A
A
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000420:Albuterol / Q000494:pharmacology; D000818:Animals; D001592:Benzyl Alcohols / Q000494:pharmacology; D005690:Galactose / Q000378:metabolism*; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects*; D007545:Isoproterenol / Q000494:pharmacology; D007583:Jejunum / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010642:Phenoxyacetates / Q000494:pharmacology; D050198:Phenoxypropanolamines; D010649:Phenylalanine / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
D000318:Adrenergic beta-Agonists; D001592:Benzyl Alcohols; D010627:Phenethylamines; D010642:Phenoxyacetates; D050198:Phenoxypropanolamines; C071909:ICI D7114; C074655:ICI 198157; C101319:trecadrine; D010649:Phenylalanine; D009921:Metaproterenol; C063157:BRL 35135; D007545:Isoproterenol; D000420:Albuterol; D005690:Galactose